Skip to main content
. 2017 Apr 13;159(6):1013–1021. doi: 10.1007/s00701-017-3164-6

Table 1.

Loss of tumor control ratios for the respective studies defined as need for a new targeted treatment against the vestibular schwannoma

Author (year) Treatment failure (leading to a new intervention)
SRS FSRT
Unger et al. [52] 3/60
Iwai et al. [22] 3/52
Myrseth et al. [36] 5/102
Hempel et al. [19] 4/123
Liu et al. [29] 2/74
Chopra et al. [10] 3/216
Fukuoka et al. [15] 12/157
Pollock et al. [44] 13/293
Nagano et al. [39] 1/87
Roos et al. [48] 2/84
Sun et al. [50] 14/190
Yomo et al. [56] 8/154
Hasegawa et al. [16, 17] 36/440
Kim et al. [24] 0/60
Boari et al. [6] 11/379
Mindermann et al. [33] 17/235
Wangerid et al. [53] 9/128
Aoyama et al. [2] 13/201
Litre et al. [28] 4/155
Total 143/2834 (5.0%) 17/356 (4.8%)